| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP of Regulatory Affairs | SVP of Regulatory Affairs
1 company
Heath-Chiozzi Margo is a SVP of Regulatory Affairs at CLDX. Recent filings cover 1 purchase and 4 sales. Those positions are worth an estimated $121K at current prices.
Our model assigns Heath-Chiozzi Margo a middling insider score of 65/100, based on 4 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +26.0%.
Heath-Chiozzi Margo's largest disclosed position is in CLDX as SVP of Regulatory Affairs, worth about $121K. The recent filings there lean toward selling, a net 97,288 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | CLDX Celldex Therapeutics, Inc. | SVP of Regulatory Affairs | Sale+OE | 58,369 | $33.65 | $1,964,087.67 | -81.3% | +24.0% | -40.6% | |
| May 30, 2024 | CLDX Celldex Therapeutics, Inc. | SVP of Regulatory Affairs | Sale+OE | 38,719 | $34.07 | $1,319,156.33 | -84.5% | +14.4% | -41.2% | |
| Dec 8, 2021 | CLDX Celldex Therapeutics, Inc. | SVP of Regulatory Affairs | Sale+OE | 600 | $40.00 | $24,000.00 | -5.1% | -28.0% | -2.3% | |
| Nov 1, 2021 | CLDX Celldex Therapeutics, Inc. | SVP of Regulatory Affairs | Sale+OE | 600 | $41.71 | $25,026.00 | -5.1% | -29.7% | -19.8% | |
| Jun 9, 2020 | CLDX Celldex Therapeutics, Inc. | SVP of Regulatory Affairs | Buy | 1,000 | $3.01 | $3,005.00 | New | - | - |